FDA staffing
This article was originally published in The Tan Sheet
Executive Summary
Sandra Kweder, MD, named ODE II acting director effective Jan. 13, filling post vacated by John Jenkins, MD, who is now Office of New Drugs director. Jenkins, Kweder essentially swapped roles, as Kweder was former acting director of Office of Review Management, now known as OND (1"The Tan Sheet" Dec. 17, 2001, p. 9)...